We cover the latest on the Covid-19 Inquiry, NHS Resolution's second Early Notifications report, the roll-out of the new Patient Safety Incident Response Framework and the implications of virtual wards.

The recent Privy Council decision in the case of Gulf View Medical Centre Limited v Tesheria [2022] UKPC 38 looked at the question of whether or not two defendants had admitted a duty of care for the others’ care.

At our webinar on 29 September, we reviewed Product Claims in a healthcare setting, which can arise in multiple types of claims.

This article considers the importance of ensuring that a participant in a clinical trial has given informed consent from a claims perspective.

NHS Resolution’s analysis of data for the first year of the Clinical Negligence Scheme for General Practice has identified that quicker and more accurate diagnosis and improved prescribing processes could result in better patient outcomes.

We cover the latest on the Covid-19 Inquiry, recommendations from the Ockenden report and NHS Resolution's thematic reviews of clinical negligence claims in emergency medicine, diabetes and lower limb complications, plus an analysis of anaesthesia claims.

From the changing landscape of vicarious liability to reforming clinical negligence in the NHS and a consultation on fixed recoverable costs amongst other topics, we analyse what these developments will mean for insurers.

Following the latest thematic review by NHS Resolution looking at the issue of diabetes and lower limb complications, we summarise when healthcare providers can step in to improve patient care, and how to prevent future harm.

The Court of Appeal determined whether the former owner of a dental practice was liable for the treatment provided to a patient by three self-employed dental associates. Find out what the decision means for healthcare providers.

In this year’s forward view, we consider issues ranging from fixed recoverable costs in clinical negligence claims, claims resulting from COVID-19 treatment, major inquiries, clinical trials and healthcare technology.

Safety of two medicines (Primodos and Sodium Valproate) and one device (pelvic mesh) was at the heart of the report of the Independent Medicines and Medical Devices Safety Review. Read the latest update on this topic.

Delays to non-Covid treatment is the leading type of claim against NHS Trusts to date, followed by Hospital-Acquired Covid (HAC) and failure to treat Covid appropriately.